Science
India's Weight-Loss Drug Market Poised for Transformation with Patent Expiration
The expiration of the patent on semaglutide in India opens the door for affordable weight-loss medications, potentially reshaping the obesity treatment landscape.
BBC World·March 18, 2026
Positivity
89
Impact
Unknown
Buzz
+0
Regional map
Where this story sits
Approximate regional placement. Stories in the same area are nudged apart when their locations overlap.
Current storySame region
On this map
India's Weight-Loss Drug Market Poised for Transformation with Patent Expiration
india
No other published articles from this region yet. This marker anchors the story for future regional clustering.
Tags:weight lossobesityindiapharmaceuticalsgenerics
Positivity score: 89